Moderna Begins Phase 3 Of Its COVID-19 Vaccine Trial

The video discusses a trial for Moderna's experimental mRNA COVID-19 vaccine, involving 30,000 volunteers. Unlike traditional vaccines, it uses mRNA to trigger an immune response. Participants receive either the vaccine or a placebo, and researchers monitor them for COVID-19 infections. Moderna aims to produce up to 1 billion doses by 2021, with potential protection lasting up to two years.

What is the main purpose of the Moderna vaccine trial?

How does Moderna's vaccine differ from traditional vaccines?

What role do volunteers play in the vaccine trial according to the text?

What will researchers track in the volunteers after they receive the vaccine?

What is the expected duration of protection from the coronavirus for those who receive two doses of the vaccine?